Cargando…
Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes
Autores principales: | Yolcu, Esma S., Shirwan, Haval, Askenasy, Nadir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366321/ https://www.ncbi.nlm.nih.gov/pubmed/28396667 http://dx.doi.org/10.3389/fimmu.2017.00342 |
Ejemplares similares
-
Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease
por: Shrestha, Pradeep, et al.
Publicado: (2023) -
Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective
por: Yolcu, Esma S., et al.
Publicado: (2017) -
Effector and Naturally Occurring Regulatory T Cells Display No Abnormalities in Activation Induced Cell Death in NOD Mice
por: Kaminitz, Ayelet, et al.
Publicado: (2011) -
Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance
por: Headen, Devon M., et al.
Publicado: (2018) -
Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)